Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial.
By L. Agodoa, L. Appel, G. Bakris, G. Beck, J. Bourgoignie, J. Briggs, J. Charleston, D. Cheek, W. Cleveland, J. Douglas and 34 more. Journal of the American Medical Association (JAMA), 2001
953 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Nephrology
View Paper: https://www.semanticscholar.org/paper/993cfbfd4ee5b8bd9b7ad7cc9ee3441276df2578
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
In Nephrology
Citations in the corpus
- The Intrarenal Renin-Angiotensin System: From Physiology to the Pathobiology of Hypertension and Kidney Disease (2007, background): “Most clinical studies also show that the glomerular filtration rate remains stable when Ang II blockade is instituted (Andersen et al., 2000; Fridman et al., 2000; Agodoa et al., 2001).”
- American College of Rheumatology Guidelines for Screening, Case Definition, Treatment and Management of Lupus Nephritis (2012, background): “ACE inhibitors or ARB treatments are superior to calcium-channel blockers and diuretics alone in preserving renal function in chronic kidney disease (24).”
- Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. (2002, methodology): “The study design has been previously described.(25,26) Briefly, participants were selfidentified African Americans with hypertension (n=1094) who were aged 18 to 70 years with a glomerular filtration rate (GFR) between 20 and 65 mL/min per 1.”
- Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. (2003, background): “ACE inhibitors, which may be preferred in special populations such as those with diabetes,(90) are also superior to amlodipine in blacks with renal disease.(62) Based exclusively on indirect comparisons, there were no significant differences between low-dose diuretics and ARBs.”